This study is a post-marketing surveillance in Japan, and it is a local prospective, company sponsored and observational study of patient who have been treated by Adalat CR for hypertension with diabetes and/or chronic kidney disease. The objective of this study is to assess safety and efficacy profile of using Adalat CR in real clinical practice. A total 2,000 patients will be recruited and be observed for 6 months. Then, patient of whom microalbumin urea and serum creatinine are continuously monitored are additionally followed for 6 months.
Study Type
OBSERVATIONAL
Enrollment
1,882
patients who are administrated with Adalat CR for hypertension
Unnamed facility
Many Locations, Japan
Evaluation of participants with Adverse Events for Safety purpose in real practice
Time frame: After 6 months
General evaluation of patient concerning efficacy of AdalatCR treatment in real practice
Time frame: After 6 months
Blood pressure, Pulse rate
Time frame: After 6 months
Clinical test values, in specially, microalbumin urea and serum creatinine
Time frame: After 6 months
Overall evaluation
Time frame: After 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.